Latest News

KKR & Co. Inc. (NYSE:KKR) sees continued growth opportunities across private credit, asset-based finance and private investment-grade lending as higher interest rates, demand for financing and evolving institutional allocations support the asset class, according to Chris Sheldon, the firm’s Co-Head

Source: magnific.com  Ask ten UK traders which broker is best and you'll get a range of answers, because the "best" broker genuinely depends on how someone trades. But when you assess brokers against the criteria that matter most to the widest range of UK traders — regulation, track record, execution quality, platform choice and market [...]

Aehr trades at a steep premium despite recent losses, while Super Micro's valuation looks cheap relative to its growth, but both carry hidden risks.

Rising bond yields can both help and hurt insurance stocks, so the latest Fed rate hike is an important development.

Fewer hit shows could mean lower returns for investors.

BioCryst Pharmaceuticals (NASDAQ:BCRX) is shifting its strategy toward external innovation as it seeks to expand beyond its ORLADEYO hereditary angioedema, or HAE, franchise, newly appointed Chief Executive Officer Charlie Gayer said at a Morgan Stanley event. Gayer, who became CEO on Jan. 1, said

Oil and gas stocks have returned to the TSX30. Here’s what drove Tenaz Energy and Valeura Energy higher and what investors should watch next.

Vital Infrastructure Property is a defensive TFSA stock that gives investors high-yield income and predictable returns.

The iShares S&P/TSX Capped Composite Index Fund (TSX:XIC) eliminates the need for stock picking.

HSBC (NYSE:HSBC) Group Chief Financial Officer Pam Kaur said the bank remains focused on investing in growth while maintaining cost discipline, with Hong Kong, wealth management, trade finance and the U.K. among its priority areas. Speaking at the Barclays Global Financial Services Conference, Kaur

Canada wants more control of critical-mineral supply chains, and Nutrien is a way to invest in one of the most strategic ones: potash for global food production.

Even before it won this big contract, Olin stock was looking cheap enough to buy.

Canada’s $100-trillion-investor summit may sound abstract, but it points to one practical theme ordinary investors can follow: electricity infrastructure.

Defence spending is shifting toward space, data, and surveillance, and MDA Space is already landing real contracts in those areas.

Whether investors realize it or not, the ruling is huge for Google's parent company and its stock.

Cybersecurity and related companies were hot with investors this week, on gloomy predictions about the future of AI.

These stocks have made some long-term investors quite rich.

The streaming giant just bought back more stock in a single quarter than ever before. But is that a reason to own it?

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined early clinical data for its RNA interference dimer program, progress in the launch of plozasiran and plans for central nervous system and metabolic disease candidates during the Morgan Stanley Global Healthcare Conference. Early Dimer Data

It takes quite a bit of money to get $500 per month in a TFSA if you invest in index funds like the iShares S&P/TSX 60 Index Fund (TSX:XIU).

It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.

The specialty retailer reported a notable insider stock disposition through indirect entities, including a family foundation.

Cybersecurity companies were having a moment on the exchange.

Huntington Bancshares (NASDAQ:HBAN) said it has revised its 2027 earnings outlook as higher-for-longer interest rates, deposit pricing pressure and competition in selected lending categories weigh on net interest margin and loan growth expectations. Speaking at the Barclays 2026 Global Financial Se

Carney’s “energy superpower” plan leans heavily on nuclear power, and Cameco sits right where more reactors meet more uranium demand.